Strategic Footprint in the News
November 15, 2022
Many medical device manufacturers are seeking alternatives to where their production takes place, especially those operating out of China. This is because China now has many risk factors—supply chain delays, rising costs, intellectual property concerns, tariffs, COVID-imposed lockdowns. This is causing medical device producers to.....
January 24, 2022
The ongoing supply chain crunch has hit the vast majority of the manufacturing sector. In a 2020 McKinsey survey, 73% of respondents encountered problems with suppliers during the pandemic.
​
That’s leading to a new push for regionalization in manufacturing, especially in industries like....
October 18, 2021
The Covid-19 pandemic has forced a moment of reckoning within the global pharmaceutical industry. At the height of the pandemic, when the need for drugs, testing materials and basic medical supplies was greater than at any time in generations, the industry couldn’t satisfy demand. Widespread shortages at the worst time possible exposed the pharmaceutical supply chain as less resilient than anyone expected. In response, industry leaders and health officials are beginning to question some of the basic assumptions that have guided pharmaceuticals manufacturing for decades.
Forbes | Business Council
June 18, 2021
Companies are leaving China in droves. A Gartner survey of supply chain leaders showed that 33% have plans to move at least a portion of their manufacturing out of China by 2023. The list of companies rethinking their subcontracting strategy includes everyone from Apple and Dell to the toymaker Hasbro. Outsourcing manufacturing to China, once the panacea for companies looking to scale manufacturing quickly and affordably, appears much less attractive than before. The question is why?
Forbes | Business Council
It’s no secret that American consumers prefer the “Made in the USA” brand label. But will people pay a premium for products made domestically?
​
In late 2020, the Reshoring Institute conducted a survey examining those very questions, with revealing results for American brands. Nearly 70% of respondents indicated that they prefer American-made products, with more than 83% of respondents willing to pay a premium of up to 20% for domestic-made products.
Forbes | Business Council
March 30, 2021
It’s no secret that American consumers prefer the “Made in the USA” brand label. But will people pay a premium for products made domestically?
​
In late 2020, the Reshoring Institute conducted a survey examining those very questions, with revealing results for American brands. Nearly 70% of respondents indicated that they prefer American-made products, with more than 83% of respondents willing to pay a premium of up to 20% for domestic-made products.
Many companies subcontract manufacturing to China, because it was less expensive. But a recent survey shows that American's prefer products "Made in the USA." Can companies bring manufacturing back to North America and still be cost-competitive?
